Abstract
Technetium-99m DMPE (99mTc-DMPE) is a newly synthesized myocardial perfusion imaging agent that shows intense myocardial accumulation in the dog. In the present study, dosimetry and potential clinical usefulness of this agent were assessed in four human subjects. Absorbed radiation doses were low, with the highest doses consisting of 200 mrad/mCi (54 μGy/MBq) to the gallbladder and 160 mrad/mCi (43 μGy/MBq) to the liver. No evidence of clinical toxicity was found. Technetium-99m DMPE did image the myocardium, but the ratio of target to nontarget activity was less favorable than that observed in the dog. Intense hepatic 99mTc-DMPE activity interfered with clinical imaging of the cardiac apex in two of the four subjects. We conclude that the prototype radiopharmaceutical, 99mTc-DMPE, is capable of myocardial perfusion imaging in man but the planar myocardial images produced are of inferior quality compared with 201Tl myocardial images. Further work is justified to develop related compounds to overcome the clinical limitations described.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkins HL, Budinger TF, Lebowitz E, Ansari AN, Greene NW, Fairchild RG, Ellis, KJ (1977) Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties. J Nucl Med 18:133–140
Bernard SR, Chen SM (1980) Dose to the gallbladder from a 99m-Tc labeled gallbladder scanning agent. Proceedings Third International Radiation Dosimetry Symposium. Oak Ridge. pp 546–553
Deutsch E, Bushong W, Glavan KA, Elder RC, Sodd VJ, Scholz KL, Fortman DL, Lukes SJ (1981) Heart imaging with cationic complexes of technetium. Science 214:85–86
Feller PA (1974) Computer assisted medical internal radiation dosimetry (CAMIRD). South Med J 67:1394
Grossman LW, Nishiyama H, Feller PA, Hoops RG, Sodd VJ (1980) Whole body scanning for radiopharmaceutical distribution in humans, Bureau of Radiological Health Symposium on Biological Effects, Imaging Techniques and Dosimetry of Ionizing Radiations, Procedings. HHS Publication (FDA) 80-8126, pp 322–327
Loevinger R, Berman M (1976) A revised scheme for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1, Revised, Society of Nuclear Medicine, New York
Nishiyama H, Deutsch E, Adolph RJ (1982a) Basal kinetic studies of Tc-99m DMPE as a myocardial imaging agent in the dog. J Nucl Med 23:1093–1102
Nishiyama H, Adolph RJ, Deutsch E (1982b) Effect of coronary blood flow on uptake and washout of Tc-99m DMPE and thallium-201. J Nucl Med 23:1102–1110
Snyder WS, Ford MR, Warner GG, Watson SB (1975) “S” absorbed dose per unit cumulated activity per selected radionuclides and organs. MIRD Pamphlet No. 11, Society of Nuclear Medicine, New York
Sorenson JA (1971) Methods for quantitating radioactivity in vivo, by external counting. Dissertation, University of Wisconsin
Author information
Authors and Affiliations
Additional information
Financial support for this study was provided by the University of Cincinnati Research Council, Cincinnati, Ohio and the National Institutes of Health, Grant HL-21276, Bethesda, Maryland
Rights and permissions
About this article
Cite this article
Gerson, M.C., Deutsch, E.A., Nishiyama, H. et al. Myocardial perfusion imaging with 99mTc-DMPE in man. Eur J Nucl Med 8, 371–374 (1983). https://doi.org/10.1007/BF00253208
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00253208